TIDES USA
Codexis’ technical experts will present at three sessions during the conference:
Spotlight Presentation:
Controlling Phosphorothioate Stereochemistry: Challenges and Innovations in Oligonucleotide Manufacturing
Stefan Lutz, PhD., Chief Scientific Officer
Thursday, May 14, 8:30–9:00 a.m.
TIDES Talk:
Superior Ligation Solutions for Scalable RNA Manufacturing
Derek Gauntlett, Vice President, Development
Wednesday, May 13, 10:25–10:35 a.m.
Conference Presentation:
Advancing Sustainability through Innovation in Oligonucleotide Manufacturing
David Entwistle, PhD., Senior Director, Program and Pipeline Management
Wednesday, May 13, 4:15–4:45 p.m.
In addition to Codexis’ talks and booth (821) presence at TIDES USA, Codexis will also host an expert panel discussion and networking event, “Stereochemistry in RNAi Manufacturing: Signal or Noise?”, on Tuesday, May 12. This panel will explore the growing industry focus on stereochemical control, manufacturing options, and its implications for therapeutic performance, and product quality. Panellists include:
- John Maraganore, PhD., Founder and Former CEO at Alnylam
- Fred Fleitz, PhD., SVP of CMC and Development Chemistry at Arrowhead Pharmaceuticals
- Alison Moore, PhD., President and CEO at Codexis
- Raman Sehgal, Entrepreneur, and Host of the Molecule to Market Podcast